Evidence map›Paper›PMID 31588031›Full record

ArticleThe Lancet. Public health2019

Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data.

Dongshan Zhu, Hsin-Fang Chung, Annette J Dobson, Nirmala Pandeya, Graham G Giles, Fiona Bruinsma, Eric J Brunner, Diana Kuh, Rebecca Hardy, Nancy E Avis and 17 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in The Lancet. Public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 241 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
241citing papers in PubMed, 7 pooled it
29.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05052749 nacompletednot on this mapstarted 2021, after this paper: background citation

Effects of High Intensity Resistance Training in Postmenopausal Women

TypeinterventionalSponsorRiphah International UniversityRan2021 to 2021Enrolled40ConditionsPost MenopauseArmsHigh Intensity Resistance Training (HIRT), Low-moderate Resistance Exercise Training
NCT07423143 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Menopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention

TypeinterventionalSponsorUmeå UniversityRan2026 to 2057Enrolled2,100ConditionsMenopause, Opportunistic SalpingectomyArmsOpportunistic salpingectomy
3 · Its place in the literature

Who cites it

241 citing papers in PubMed, 7 syntheses or guidelines pooled it, 481 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Review
  14. Hormone therapy (HT) in women with premature ovarian insufficiency or early menopause: Time to think of a new paradigm for healthy aging. A joint FIGO and IMS position paper.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational

181 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 18 institutions in 8 countries.

Dongshan ZhuSchool of Public Health, University of Queensland, Brisbane, QLD, Australia.
Hsin-Fang ChungSchool of Public Health, University of Queensland, Brisbane, QLD, Australia.
Annette J DobsonSchool of Public Health, University of Queensland, Brisbane, QLD, Australia.
Nirmala PandeyaSchool of Public Health, University of Queensland, Brisbane, QLD, Australia; Department of Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Graham G GilesCancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Fiona BruinsmaCancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
Eric J BrunnerDepartment of Epidemiology and Public Health, University College London, London, UK.
Diana KuhMedical Research Council Unit for Lifelong Health and Ageing, University College London, London, UK.
Rebecca HardyMedical Research Council Unit for Lifelong Health and Ageing, University College London, London, UK.
Nancy E AvisDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Ellen B GoldDepartment of Public Health Sciences, University of California, Davis School of Medicine, Davis, CA, USA.
Carol A DerbyDepartment of Neurology, Albert Einstein College of Medicine, New York, NY, USA; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, NY, USA.
Karen A MatthewsDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
Janet E CadeNutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, UK.
Darren C GreenwoodNutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, UK.
Panayotes DemakakosDepartment of Epidemiology and Public Health, University College London, London, UK.
Daniel E BrownDepartment of Anthropology, University of Hawaii, Hilo, HI, USA.
Lynnette L SievertDepartment of Anthropology, University of Massachusetts Amherst, Amherst, MA, USA.
Debra AndersonMenzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
Kunihiko HayashiSchool of Health Sciences, Gunma University, Maebashi, Japan.
Jung Su LeeDepartment of Public Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Hideki MizunumaFukushima Medical Center for Children and Women, Fukushima Medical University, Fukushima, Japan.
Therese TillinInstitute of Cardiovascular Science, University College London, London, UK.
Mette Kildevæld SimonsenParker Institute, Copenhagen University Hospital, Frederiksberg, Denmark; Aarhus University, Aarhus, Denmark.
Hans-Olov AdamiDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
Elisabete WeiderpassInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Gita D MishraSchool of Public Health, University of Queensland, Brisbane, QLD, Australia. Electronic address: g.mishra@uq.edu.au.
University College London · GBUniversity of Queensland · AUUniversity of Leeds · GBAarhus University · DKAlbert Einstein College of Medicine · USCancer Council Victoria · AUCentre International de Recherche sur le Cancer · FRFukushima Medical University · JPGriffith University · AUGunma University · JPThe University of Tokyo · JPUniversity of California, Davis · USUniversity of Hawaii at Hilo · USUniversity of Massachusetts Amherst · USUniversity of Melbourne · AUUniversity of Oslo · NOUniversity of Pittsburgh · USWake Forest University · US

Funding

WOMENS HEALTH ACROSS THE NATION--UCLAU01AG012539 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GREENDALE, GAIL A · 1994 to 2018
$13.7M
WOMENS HEALTH ACROSS THE NATION--CHICAGOU01AG012505 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI KRAVITZ, HOWARD M · 1994 to 2019
$11.9M
British Heart Foundation RG/13/2/30098British Heart Foundation RG/16/11/32334NIA NIH HHS U01 AG012505NIA NIH HHS U01 AG012539World Health Organization 001
6 · The paper itself

Abstract

backgroundEarly menopause is linked to an increased risk of cardiovascular disease mortality; however, the association between early menopause and incidence and timing of cardiovascular disease is unclear. We aimed to assess the associations between age at natural menopause and incidence and timing of cardiovascular disease.

methodsWe harmonised and pooled individual-level data from 15 observational studies done across five countries and regions (Australia, Scandinavia, the USA, Japan, and the UK) between 1946 and 2013. Women who had reported their menopause status, age at natural menopause (if postmenopausal), and cardiovascular disease status (including coronary heart disease and stroke) were included. We excluded women who had hysterectomy or oophorectomy and women who did not report their age at menopause. The primary endpoint of this study was the occurrence of first non-fatal cardiovascular disease, defined as a composite outcome of incident coronary heart disease (including heart attack and angina) or stroke (including ischaemic stroke or haemorrhagic stroke). We used Cox proportional hazards models to estimate multivariate hazard ratios (HRs) and 95% CIs for the associations between age at menopause and incident cardiovascular disease event. We also adjusted the model to account for smoking status, menopausal hormone therapy status, body-mass index, and education levels. Age at natural menopause was categorised as premenopausal or perimenopausal, younger than 40 years (premature menopause), 40-44 years (early menopause), 45-49 years (relatively early), 50-51 years (reference category), 52-54 years (relatively late), and 55 years or older (late menopause).

findingsOverall, 301 438 women were included in our analysis. Of these 301 438 women, 12 962 (4·3%) had a first non-fatal cardiovascular disease event after menopause, of whom 9369 (3·1%) had coronary heart disease and 4338 (1·4%) had strokes. Compared with women who had menopause at age 50-51 years, the risk of cardiovascular disease was higher in women who had premature menopause (age <40 years; HR 1·55, 95% CI 1·38-1·73; p<0·0001), early menopause (age 40-44 years; 1·30, 1·22-1·39; p<0·0001), and relatively early menopause (age 45-49 years; 1·12, 1·07-1·18; p<0·0001), with a significantly reduced risk of cardiovascular disease following menopause after age 51 years (p<0·0001 for trend). The associations persisted in never smokers, and were strongest before age 60 years for women with premature menopause (HR 1·88, 1·62-2·20; p<0·0001) and early menopause (1·40, 1·27-1·54; p<0·0001), but were attenuated at age 60-69 years, with no significant association observed at age 70 years and older.

interpretationCompared with women who had menopause at age 50-51 years, women with premature and early menopause had a substantially increased risk of a non-fatal cardiovascular disease event before the age of 60 years, but not after age 70 years. Women with earlier menopause need close monitoring in clinical practice, and age at menopause might also be considered as an important factor in risk stratification of cardiovascular disease for women.

fundingAustralian National Health and Medical Research Council.

Indexed as

MenopauseAdultAgedAge FactorsBody Mass IndexCardiovascular DiseasesCoronary DiseaseEducational StatusEstrogen Replacement TherapyFemaleHumansIncidenceMiddle AgedObservational Studies as TopicProportional Hazards ModelsRisk Assessment

Identifiers

PMID31588031
PMCPMC7118366
OpenAlexW2978261942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.